FARMINGTON HILLS, Mich., May 06, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (Ocuphire), a clinical-stage biopharmaceutical company focused on developing novel therapies for the...
FARMINGTON HILLS, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (Ocuphire), a clinical-stage biopharmaceutical company focused on developing novel therapies for...